1. Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care;DA Lane;J Am Heart Assoc,2017
2. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS;P Kirchhof;Eur Heart J,2016
3. The Danish Counsil for the Use of Expensive Hospital Medicines [Rådet for Anvendelse af Dyr Sygehusmedicin]. Background memorandum for oral anticoagulant therapy in non-valvular atrial fibrillation [Baggrundsnotat for oral antikoagulationsbehandling ved non-valvulær atrieflimren] 2016:1–8. http://www.regioner.dk/media/3415/beh-atrieflimmer-juni-2016.pdf (accessed January 13, 2017).
4. Warfarin Anticoagulation and Outcomes in Patients With Atrial Fibrillation—A Systematic Review and Metaanalysis;MW Reynolds;CHEST,2004
5. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review;Y Wan;Circ Cardiovasc Qual Outcomes,2008